| Name | CKD-519 |
|---|---|
| Synonyms |
CKD519,CKD
Rocacetrapib 2-Oxazolidinone, 5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-[4-fluoro-2-methoxy-5-(1-methylethyl)phenyl]-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-4-methyl-, (4S,5R) |
| Description | CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor, which inhibits CETP-mediated transfer of cholesteryl ester in human serum with an IC50 of 2.3 nM[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 2.3 nM (Cholesteryl ester transfer protein)[1] |
| References |
| Molecular Formula | C31H34F7NO3 |
|---|---|
| Molecular Weight | 601.60 |